A revolutionary drug , retatrutide, is generating considerable buzz within the Australian weight control community. Developed by Lilly , this twin GIP and GLP-1 agonist appears to deliver more substantial benefits than existing therapies. Preliminary clinical trials have shown exceptional reductions in body fat , suggesting a for a new approach … Read More